Barbaro V, Bartolini P, Donato A, Militello C, Altamura G, Ammirati F, Santini M
Biomedical Engineering Laboratory, San Filippo Neri Hospital, Rome, Italy.
Pacing Clin Electrophysiol. 1995 Jun;18(6):1218-24. doi: 10.1111/j.1540-8159.1995.tb06961.x.
A series of in vivo trials were carried out in order to verify whether the electromagnetic field radiated by GSM (Groupe Systemes Mobiles) mobile cellular phones might affect implanted pacemakers. Two European GSM phones of 2-watt power were tested and trials conducted on 101 pacemaker implanted outpatients attending day hospital for routine check-up, who volunteered for trials. Forty-three pacemaker models from 11 manufacturers were tested in all. When the sensing threshold of the pacemakers was set at a minimum and the antenna of the phone was in direct contact with the patient's chest, interference was detected for 26 implanted pacemakers. Specifically, pulse inhibition in 10 of 101 cases, ventricular triggering in 9 of 46 DDD-VDD pacemakers, and asynchronous pacing in 4 of 52 devices. Pulse inhibition was also observed combined with asynchronous pacing in 1 of 52 cases and with ventricular triggering in 2 of 46 cases. Minimum effect duration was ca. 3 seconds but in 6 cases effects continued as long as the interfering GSM signal was on. No permanent malfunctioning or changes in the programmed parameters were detected. Whenever interference was detected, trials were repeated to determine the maximum sensing threshold at which interference persisted (with the antenna in contact with the skin over the pacemaker). Then maximum distance between antenna and pacemaker at which interference occurred was determined at pacemaker maximum and minimum sensing threshold. Under our experimental conditions electromagnetic interference effects were detected at a maximum distance of 10 cm with the pacemaker programmed at its minimum sensing threshold.(ABSTRACT TRUNCATED AT 250 WORDS)
为了验证全球移动通信系统(GSM)移动蜂窝电话辐射的电磁场是否会影响植入式起搏器,进行了一系列体内试验。测试了两部功率为2瓦的欧洲GSM手机,并对101名在日间医院进行常规检查的植入起搏器的门诊患者进行了试验,这些患者自愿参与试验。总共测试了来自11家制造商的43种起搏器型号。当起搏器的感知阈值设置为最低且手机天线直接接触患者胸部时,在26个植入式起搏器中检测到干扰。具体而言,101例中有10例出现脉冲抑制,46个DDD-VDD起搏器中有9例出现心室触发,52个设备中有4例出现异步起搏。在52例中有1例观察到脉冲抑制与异步起搏同时出现,在46例中有2例与心室触发同时出现。最小影响持续时间约为3秒,但在6例中,只要干扰的GSM信号存在,影响就会持续。未检测到永久性故障或编程参数的变化。每当检测到干扰时,就会重复试验以确定干扰持续存在时的最大感知阈值(天线与起搏器上方皮肤接触)。然后在起搏器最大和最小感知阈值下确定天线与起搏器之间出现干扰的最大距离。在我们的实验条件下,当起搏器编程为其最小感知阈值时,在最大距离10厘米处检测到电磁干扰效应。(摘要截断于250字)